Lyophilized from 20 mM Tris (pH 8.0) with 150 mM NaCl, 1 mM EDTA, 1 mM DTT, 0.01% SKL, 5% Trehalose, Proclin300. Reconstitute with 20 mM Tris and 150 mM NaCl (pH 8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
Lagerung:
2°C to 8°C, -20°C
Target-Kategorie:
colony stimulating factor 2
Application Verdünnung:
TF-1, the human erythroleukemia cell line, provides a good system for detecting the activity of GM-CSF for it is a cell line of immature erythroid origin that completely depends on interleukin 3 (IL-3) or granulocyte-macrophage colony-stimulating factor
Anwendungsbeschreibung:
TF-1, the human erythroleukemia cell line, provides a good system for detecting the activity of GM-CSF for it is a cell line of immature erythroid origin that completely depends on interleukin 3 (IL-3) or granulocyte-macrophage colony-stimulating factor (
Cell differentiation effect of GTX00082-pro Human GM-CSF protein (active). (A) Unstimulated U937 cells cultured in RPMI-1640. (B) U937 cells cultured in RPMI-1640, stimulated with GM-CSF (10 ng/ml).
Cell proliferation effect of GTX00082-pro Human GM-CSF protein (active). (A) Unstimulated TF-1 cells cultured in RPMI-1640. (B) TF-1 cells cultured in RPMI-1640, stimulated with GM-CSF (2 ng/ml).
WB analysis of GTX00082-pro Human GM-CSF protein (active).
SDS-PAGE analysis of GTX00082-pro Human GM-CSF protein (active).
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten